[go: up one dir, main page]

SE9804248D0 - Anti-coagulation with calcium containing citrate solution - Google Patents

Anti-coagulation with calcium containing citrate solution

Info

Publication number
SE9804248D0
SE9804248D0 SE9804248A SE9804248A SE9804248D0 SE 9804248 D0 SE9804248 D0 SE 9804248D0 SE 9804248 A SE9804248 A SE 9804248A SE 9804248 A SE9804248 A SE 9804248A SE 9804248 D0 SE9804248 D0 SE 9804248D0
Authority
SE
Sweden
Prior art keywords
product
blood
coagulated
coagulant
blood product
Prior art date
Application number
SE9804248A
Other languages
Swedish (sv)
Inventor
Mats Raanby
Original Assignee
Global Hemostasis Inst Mgr Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Global Hemostasis Inst Mgr Ab filed Critical Global Hemostasis Inst Mgr Ab
Priority to SE9804248A priority Critical patent/SE9804248D0/en
Publication of SE9804248D0 publication Critical patent/SE9804248D0/en
Priority to AU20174/00A priority patent/AU2017400A/en
Priority to PCT/SE1999/002271 priority patent/WO2000033853A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A method of anti-coagulating a blood product and counteracting the reduction of calcium ion activity in the anti-coagulated product, is disclosed. The method comprises addition to the blood product of an anti-coagulant selected from the group consisting of soluble citrate compounds, citric acid, and mixtures thereof in an amount of 13-60 mmole citrate per liter of anti-coagulated blood product, and of a soluble calcium compound in an amount giving a calcium ion activity in the anti-coagulated blood product of 0.2 - 10mM. Further, an anti-coagulated blood or blood plasma product comprising such an anti-coagulant and calcium compound, and its use for the production of coagulation Factor VIII, are described. Additionally, a blood sampling container comprising an aqueous solution of such an anti-coagulant and calcium compound, and its use for transport and storage of the anti-coagulated blood product, are disclosed.
SE9804248A 1998-12-07 1998-12-07 Anti-coagulation with calcium containing citrate solution SE9804248D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE9804248A SE9804248D0 (en) 1998-12-07 1998-12-07 Anti-coagulation with calcium containing citrate solution
AU20174/00A AU2017400A (en) 1998-12-07 1999-12-06 Anti-coagulation with calcium containing citrate solution
PCT/SE1999/002271 WO2000033853A1 (en) 1998-12-07 1999-12-06 Anti-coagulation with calcium containing citrate solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9804248A SE9804248D0 (en) 1998-12-07 1998-12-07 Anti-coagulation with calcium containing citrate solution

Publications (1)

Publication Number Publication Date
SE9804248D0 true SE9804248D0 (en) 1998-12-07

Family

ID=20413589

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9804248A SE9804248D0 (en) 1998-12-07 1998-12-07 Anti-coagulation with calcium containing citrate solution

Country Status (3)

Country Link
AU (1) AU2017400A (en)
SE (1) SE9804248D0 (en)
WO (1) WO2000033853A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8105258B2 (en) 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US7186420B2 (en) 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
EP1176969B1 (en) 1999-04-26 2008-08-20 Edwards Lifesciences AG Substitution infusion fluid and citrate anticoagulation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3615558A1 (en) * 1986-05-09 1987-11-12 Behringwerke Ag METHOD FOR PRODUCING A FACTOR V CONCENTRATE
GB8708181D0 (en) * 1987-04-06 1987-05-13 Wensley R Extraction of protein from blood

Also Published As

Publication number Publication date
WO2000033853A1 (en) 2000-06-15
AU2017400A (en) 2000-06-26

Similar Documents

Publication Publication Date Title
EP1281722A4 (en) HYALURONIC ACID GEL, METHOD FOR THE PRODUCTION THEREOF, AND THE MEDICAL MATERIAL CONTAINING GEL
WO2000049084A8 (en) Hyaluronic acid gel composition, process for producing the same, and medical material containing the same
BR9607922A (en) Final drug product of a plasma protein Processes to prepare the final drug product to improve the long-term stability of a plasma protein and to treat hemophilia and use of a final drug product
SG53690G (en) New compounds having antiinflammatory activity,obtained by complexation with beta-cyclodextrin,and pharmaceutical compositions containing them
ATE218354T1 (en) OXYGEN REDUCED AQUEOUS FACTOR VIII SOLUTION CONTAINING
CA2116066A1 (en) Stabilized composition of troponin for immunoassays and process for stabilizing troponin for immunoassays
DE50310078D1 (en) USE OF 2,6-DI-TERT.-BUTYL-P-KRESOL FOR THE ERH
MY113981A (en) Pharmaceutical composition containing a diclofenac salt and 2-hydroxypropyl-b-cyclodextrin
IL84911A (en) Processes for the preparation of collagen products, and pharmaceutical compositions containing the same
EP2292096A3 (en) Active bromine containing biocidal compositions and their preparation
ATE277126T1 (en) ION COMPLEX, COATING MATERIAL, AND COATING PROCESS
AU3369299A (en) Stable concentrated rare earth carboxylate liquids
EP0147464A4 (en) Chemically active aqueous solution and solid substance containing ferrous ion.
ATE230274T1 (en) PHYSIOLOGICALLY ACTIVE DELAYED RELEASE PREPARATION CONTAINING POLYPEPTIDE AND PRODUCTION THEREOF
SE9804248D0 (en) Anti-coagulation with calcium containing citrate solution
AR009582A1 (en) PREPARATION PROCEDURE OF A MEDICINAL PRODUCT CONTAINING PLASMA PROTEIN FROM CITRATED PLASMA OR FROM A FRACTION OF PLASMAQUE CONTAINS CITRATE
ITMI20000665A0 (en) GLYCOSAMINOGLICANS DERIVED FROM THE K5 POLYSACCHARIDE WITH HIGH ANTICOAGULANT AND ANTITHROMBOTIC ACTIVITY AND PROCESS FOR THEIR PREPARATION
DE69811758D1 (en) Use of hyaluronic acid for the preparation of an aqueous solution useful as an intra-articular cleaning solution
MY112593A (en) A storage stable water solution for infusion containing a thrombin inhibitor
AU8045498A (en) Anti-coagulation of blood, blood plasma or synovial fluid products
DE50001654D1 (en) METHOD FOR PRODUCING POLYVINYLPYRROLIDONE IODINE IN AQUEOUS SOLUTION
DE69016249D1 (en) Process for the electrochemical treatment of gas containing hydrogen sulfide.
AU2002211063A1 (en) Fluid for haemofiltration
JPS63220872A (en) Deodorants
AU2002215860A1 (en) Material for detoxification of blood containing foreign toxic substances